Dual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD
Speaker: Ricardo Diaz, MD
Title: Dual Regimen – What Are the Resistance Considerations
Presented at: Session 2 - Antiretroviral Therapy 2022 - Dual Regimens
African HIV Clinical Forum 2022
https://academicmedicaleducation.com/meeting/african-hiv-clinical-forum-2022
For more information, please visit: https://academicmedicaleducation.com
Subscribe to our newsletter: https://amededu.activehosted.com/f/13
Видео Dual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD канала Academic Medical Education
Title: Dual Regimen – What Are the Resistance Considerations
Presented at: Session 2 - Antiretroviral Therapy 2022 - Dual Regimens
African HIV Clinical Forum 2022
https://academicmedicaleducation.com/meeting/african-hiv-clinical-forum-2022
For more information, please visit: https://academicmedicaleducation.com
Subscribe to our newsletter: https://amededu.activehosted.com/f/13
Видео Dual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD канала Academic Medical Education
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Invitation to Asia-Pacific HIV Clinical Forum 2021 by Session Chair - Kiat Ruxrungtham, MD
Preview: Highlights International Workshop on HIV & Women 2021 | Sharon Walmsley, FRCPC, MD, MSC
A new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MD
Overview of PrEP in the Asia-Pacific | Heather Marie Schmidt, BMedSc(Hon), MPH, PhD
Clinical Considerations of Aging People Living with HIV - Marta Boffito
The ABC of viral hepatitis | Mark Thursz, MRCP
Updates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhD
Healthy Living with HIV Workshop: Session 4 | Live Style with HIV
Clinical Review: New RT inhibitors – Islatravir - Jean-Michel Molina, MD, PhD,
Is HCV drug resistance an issue? | Jürgen Rockstroh, MD
Is NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF
Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun
Immunology and Inflammation - Victor Appay, PhD
Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD
Exercise and aging | Wendy Kohrt, PhD
Стигма и дискриминация в контексте группы людей, употребляющих инъекционные наркотики - Петр Мейлахс
Symposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel Discussion
Invitation to join the HIV Prevention Review Meeting 2022 - 30-31 March
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Case-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhD
Anti-HBV potential of PD-1/PD-L1 blockade in chronic HBV infection | Daniel Verdon